Our findings demonstrate that hepatic IL-6/STAT3 signaling also contributes to maintaining metabolic homeostasis in the face of an intestinal microbiome that can induce mature-onset body fat accumulation and hyperglycemia when IL-6 trans-signaling is inhibited. Here, STAT3 is linked to Hyperglycemia.